These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Virus and cell requirements for Friend virus granulocytic leukemogenesis in long-term bone marrow cultures of NIH swiss [N:NIH(S)] mice. Greenberger JS; Newburger PE; Lipton JM; Moloney WC; Sakakeeny MA; Jackson PL J Natl Cancer Inst; 1980 Apr; 64(4):867-78. PubMed ID: 6928998 [TBL] [Abstract][Full Text] [Related]
3. Inducibility of spleen focus-forming virus by BrdUrd is controlled by the differentiated state of the cell. Greiser-Wilke I; Ostertag W; Goldfarb P; Lang A; Furusawa M; Conscience JF Proc Natl Acad Sci U S A; 1981 May; 78(5):2995-9. PubMed ID: 6265929 [TBL] [Abstract][Full Text] [Related]
4. Friend erythroleukemia virus complex: role of viral components in modifying erythroid differentiation in mice. Fagg B; Ostertag W J Natl Cancer Inst; 1982 Mar; 68(3):457-60. PubMed ID: 6950173 [TBL] [Abstract][Full Text] [Related]
5. Lack of retrovirus gene expression in somatic cell hybrids of friend cells and teratocarcinoma cells with a teratocarcinoma phenotype. Asche W; Colletta G; Warnecke G; Nobis P; Pennie S; King RM; Ostertag W Mol Cell Biol; 1984 May; 4(5):923-30. PubMed ID: 6727874 [TBL] [Abstract][Full Text] [Related]
6. Anemia- and polycythemia-inducing isolates of Friend spleen focus-forming virus. Biological and molecular evidence for two distinct viral genomes. MacDonald ME; Reynolds FH; Van de Ven WJ; Stephenson JR; Mak TW; Bernstein A J Exp Med; 1980 Jun; 151(6):1477-92. PubMed ID: 6929880 [TBL] [Abstract][Full Text] [Related]
7. Helper virus is not required for in vitro erythroid transformation of hematopoietic cells by Friend virus. Hankins WD; Krantz SB Proc Natl Acad Sci U S A; 1980 Sep; 77(9):5287-91. PubMed ID: 6933561 [TBL] [Abstract][Full Text] [Related]
8. Transformation of DBA/2 mouse fetal liver cells infected in vitro by the anemic strain of Friend leukemia virus. Golde DW; Bersch N; Friend C; Tsuei D; Marovitz W Proc Natl Acad Sci U S A; 1979 Feb; 76(2):962-6. PubMed ID: 284421 [TBL] [Abstract][Full Text] [Related]
9. Induction of erythroid tumorigenic colonies by Friend helper virus F-MuLV alone and isolation of a new class of friend erythroleukemic cells. Shibuya T; Mak TW J Cell Physiol Suppl; 1982; 1():185-94. PubMed ID: 6950942 [No Abstract] [Full Text] [Related]
10. Expression of a transformation-related protein (p53) in the malignant stage of Friend virus-induced diseases. Ruscetti SK; Scolnick EM J Virol; 1983 Jun; 46(3):1022-6. PubMed ID: 6343627 [TBL] [Abstract][Full Text] [Related]
11. Friend murine leukemia virus and spleen focus-forming virus expression in highly malignant interferon-sensitive and interferon-resistant Friend leukemia cells. Oppi C; Fiorucci G; Ferrantini M; Battistini A; Belardelli F Virology; 1986 Apr; 150(2):390-401. PubMed ID: 2421480 [TBL] [Abstract][Full Text] [Related]
12. Cellular regulation in Friend virus induced erythroleukemia. Studies with anemic mice of genotype Sl/Sld. McCool D; Mak TW; Bernstein A J Exp Med; 1979 Apr; 149(4):837-46. PubMed ID: 285212 [TBL] [Abstract][Full Text] [Related]
13. Quantitative colony method for tumorigenic cells transformed by two distinct strains of Friend leukemia virus. Mager DL; Mak TW; Bernstein A Proc Natl Acad Sci U S A; 1981 Mar; 78(3):1703-7. PubMed ID: 6940184 [TBL] [Abstract][Full Text] [Related]
14. Friend erythroleukemia antigen. A viral antigen specified by spleen focus-forming virus and differentiation antigen controlled by the Fv-2 locus. Risser R J Exp Med; 1979 May; 149(5):1152-67. PubMed ID: 448285 [TBL] [Abstract][Full Text] [Related]
15. Malignant myelomonocytic cells after in vitro infection of marrow cells with Friend leukaemia virus. Testa NG; Dexter TM; Scott D; Teich NM Br J Cancer; 1980 Jan; 41(1):33-9. PubMed ID: 6928787 [TBL] [Abstract][Full Text] [Related]
16. Induction of endogenous and of spleen focus-forming viruses during dimethylsulfoxide-induced differentiation of mouse erythroleukemia cells transformed by spleen focus-forming virus. Dube SK; Pragnell IB; Kluge N; Gaedicke G; Steinheider G; Ostertag W Proc Natl Acad Sci U S A; 1975 May; 72(5):1863-7. PubMed ID: 1057176 [TBL] [Abstract][Full Text] [Related]
17. Persistence and pathogenicity of defective Friend spleen focus-forming virus. Decreased transplantability of hemopoietic cells as a marker for preleukemic change. Eckner RJ; Hettrick KL J Exp Med; 1979 Feb; 149(2):340-57. PubMed ID: 762497 [TBL] [Abstract][Full Text] [Related]
18. Characterization of myelomonocytic leukemia cells induced by in vitro infection of bone marrow with FLV. Testa NG; Dexter TM; Teich NM Haematol Blood Transfus; 1979; 23():231-5. PubMed ID: 544363 [No Abstract] [Full Text] [Related]
19. The detection of a spleen focus-forming virus neoantigen by lymphocyte-mediated cytolysis. Gillis S; Gillis AE; Smith KA J Exp Med; 1978 Jul; 148(1):18-31. PubMed ID: 78957 [TBL] [Abstract][Full Text] [Related]
20. Friend spleen focus-forming virus production in vitro by a nonerythroid cell line. Clarke BJ; Axelrad AA; Housman D J Natl Cancer Inst; 1976 Oct; 57(4):853-9. PubMed ID: 1069858 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]